Chemed reports Q3 2025 results via press release

Chemed Corporation filed a current report stating that on October 28, 2025 it issued a press release announcing its financial results for the quarter ended September 30, 2025.

Accepted by SEC EDGAR 10/28/2025 - 04:31 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Chemed Corporation filed a current report stating that on October 28, 2025 it issued a press release announcing its financial results for the quarter ended September 30, 2025. The company notes that this press release is furnished as Exhibit 99 to the report, making the detailed quarterly results available through that exhibit.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Chemed (CHE) disclose in this Form 8-K?

Chemed reported that it issued a press release announcing its financial results for the quarter ended September 30, 2025, and furnished that release as Exhibit 99.

Which period do the reported Chemed (CHE) results cover?

The financial results discussed in the press release relate to Chemed’s quarter ended September 30, 2025.

When did Chemed issue the press release about its quarterly results?

Chemed issued the press release on October 28, 2025, the same date referenced as the event date in the report.

Where can investors find the detailed Chemed Q3 2025 results?

The detailed quarterly results are contained in Chemed’s press release, which is furnished as Exhibit 99 to this report.

Which item of the 8-K does Chemed use to report these results?

Chemed reports the quarterly financial results under Item 2.02 Results of Operations and Financial Condition.

Who signed this Chemed (CHE) Form 8-K?

The report was signed on behalf of Chemed Corporation by Michael D. Witzeman, Executive Vice President and Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

false000001958400000195842025-10-282025-10-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):

October 28, 2025

CHEMED CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	1-8351	31-0791746
(State or other ‎jurisdiction of ‎incorporation)	(Commission File Number)	(I.R.S. Employer ‎Identification ‎Number)

2600 First Financial Center, 255 East 5th Street, Cincinnati, OH 45202

(Address of principal executive offices)             (Zip Code)

Registrant's telephone number, including area code:

(513) 762-6690

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

[_]      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[_]      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)

[_]      Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b))

[_]      Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to 12(b) of the Act:

Title of each class	Trading symbol	Name of each exchange on which registered
Capital stock $1 par value	CHE	NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.  [_]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [_]

Page 1 of 3

Item 2.02 Results of Operations and Financial Condition

On October 28, 2025, Chemed Corporation issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of the release is furnished herewith as Exhibit 99.

Item 9.01 Financial Statements and Exhibits

d)	Exhibit
	(99) Registrant’s press release dated September 30, 2025
	104 The cover page from this Current Report on Form 8-K formatted in Inline XBRL

Page 2 of 3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		CHEMED CORPORATION
Dated:   October 28, 2025		By:	/s/ Michael D. Witzeman
			Michael D. Witzeman
			Executive Vice President and Chief Financial Officer

Page 3 of 3